BVF Partners L P/il, 10% Owner at Xenon Pharmaceuticals Inc. (XENE), bought 566,487 shares at $3.75 ($2.2M) on 2017-06-06, disclosed to the SEC on 2017-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.75 | 913 | $3K | 0.2% |
| 2 | $3.75 | 53,260 | $200K | 9.2% |
| 3 | $3.75 | 96,736 | $363K | 16.7% |
| 4 | $3.85 | 20,594 | $79K | 3.7% |
| 5 | $3.85 | 20,594 | $79K | 3.7% |
| 6 | $3.85 | 73,749 |
| $284K |
| 13.1% |
| 7 | $3.85 | 73,749 | $284K | 13.1% |
| 8 | $3.85 | 113,446 | $437K | 20.2% |
| 9 | $3.85 | 113,446 | $437K | 20.2% |
| Total | $3.82 avg | 566,487 | $2.2M | 100% |
| Filing → |
| KYMR | BUY | 2022-05-31 | $8.3M | — | Filing → |
| IDYA | SELL | 2021-02-04 | $835K | — | Filing → |
| XOMA | BUY | 2020-03-27 | $284K | — | Filing → |